Wiley, et al., J. Med. Chem., vol. 43, pp. 883-899 (2000). |
Pinto, et al., J. Med. Chem., vol. 44, pp. 566-578 (2001). |
Xu, et al., Synthesis, vol. 7, pp. 556-558 (1983). |
Saulnier, et al., J. Am. Chem. Soc., vol. 111, pp. 8320-8321 (1989). |
Thrombosis and Haemostasis, vol 74(2), pp. 635-639, 1995. |
Thrombosis Research, vol. 83, pp. 117-126, 1996. |
European Journal of Pharmacology, vol. 352, pp. 59-63, 1998. |
Journal of Medicinal Chemistry, vol. 43, pp. 4398-4415, 2000. |
Journal of Medicinal Chemistry, vol. 43, pp. 883-899, 2000. |
Journal of Medicinal Chemistry, vol. 44, pp. 566-578, 2001. |
R.R. Tidwell, et al., “Strategies for Anticoagulation with Synthetic Protease Inhibitors, Xa Inhibitors versus Thrombin Inhibitors”, Thrombosis Research, vol. 19, pp. 339-349, 1980. |
David J. Robison, et al., “Active Site of Bovine Factor Xa, Characterization using Substituted Benzamidines as Competitive Inhibitors and Affinity-Labeling Reagents”, The Journal Of Biological Chemistry, vol. 255, No. 5, Issue of Mar. 10, pp. 2014-2021, 1980. |
Wong, et al., Thrombosis Research, vol. 83, No. 2, pp. 117-126 (1996). |
Han, et al., J. Med. Chem., vol. 43, pp. 4398-4415 (2000). |
Drake NL, in Organic Reactions, vol. 1, Chapter 5, pp. 105-128, Wiley, NY, 1942. |